Mitchell J. Wagner

Mitchell J. Wagner

Auto-generated profile, based on publicly available information

Mitchell J. Wagner

Department of Surgery, University of Alberta, Edmonton, AB, Canada

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
18 June 2024 in Journal of the American Heart Association
Verified
Journal Article
Open access
MWMitchell J. Wagner
Mitchell J. Wagner
AJAamir Jeewa
Aamir Jeewa
TPTara Pidborochynski
Tara Pidborochynski
SLSamuel Lemaire‐Paquette
Samuel Lemaire‐Paquette
MKMichael Khoury
Michael Khoury
JCJennifer Conway
Jennifer Conway
Background: Hypertrophic cardiomyopathy is a burdensome condition that inflicts both physical and psychological impairment on those with the disease, negatively impacting health‐related quality of life (HRQoL). Given the abundance of evidence suggesting a role of physical activity (PA) in modulating HRQoL in healthy populations of children, we sought to determine the relationship between HRQoL and PA in children diagnosed with hypertrophic cardiomyopathy. Methods and Results: A multicenter prospective observational cohort study was conducted, with patients with hypertrophic cardiomyopathy aged 10 to 19 years being provided a wrist‐worn activity tracker (Fitbit Charge HR) to wear for 14 days. Patients self‐reported on Pediatric Quality of Life 4.0 quality of life inventory items, which were associated with PA metrics following covariate adjustment using linear regression. A total of 56 participants were recruited to the study. The median age at enrollment was 15.5 years (interquartile range, 13.8–16.8), and 16 out of 56 (29%) of the cohort were girls. The cohort reported decreased metrics of physical, psychosocial, and total summary scores compared with health reference populations, with scores comparable with that of published populations with chronic disease. Increased physical HRQoL scores were significantly associated with increased daily steps taken, distance traveled, and flights of stairs climbed. Conclusions: These results show that impaired PA correlates with reduced HRQoL in children with hypertrophic cardiomyopathy, suggesting PA may partially mediate HRQoL in this population.

28 August 2024 in Canadian Association of Radiologists Journal
Verified
Journal Article
Open access
MWMitchell Wagner
Mitchell Wagner
KSKarim Samji
Karim Samji
Background/Objective: We sought to characterize the proportion of peripheral zone lesions “upgraded” within the PI-RADS v2.1 protocol using DCE imaging sequences in a large patient population undergoing multiparametric prostate MRI. Methods: A retrospective review of radiologist reports for 2742 prostate MRI exams at 2 large Alberta teaching hospitals between January 2017 and January 2022 was conducted. Prostate specific antigen (PSA), prostate volume, sequence specific and overall PI-RADS scores, and lesion positivity for DCE were collected if present in the accompanying radiology report. Further, pathology reports of biopsies of the upgraded lesions within upgraded patients were reviewed to see if upgraded lesions were deemed clinically significant by gleason score/grade group. Results: The median age was 63 years, with a median PSA and PSA density of 7.5 ng/mL and 0.13 ng/mL 2 respectively. A total of 1809 lesions were reported, with 69.4% of all lesions being DCE positive. Of the lesions within the peripheral zone, 548 were overall PI-RADS 4. A total of 87/2742 (3.2%) of patients were upgraded to a PI-RADS 4 by DCE imaging. Within these patients, 65 had pathology reports available, of which 18 had a clinically significant lesion at the upgrade site. Conclusion: Contrast enhancement is only beneficial for a very small portion of patients undergoing prostate MRI. Given the invasive nature of contrast enhanced studies, potential contrast induced side effects, added imaging time, and the cost of contrast agent, routine use of contrast for prostate MRI is questioned. Further studies are necessary to determine if it should be part of routine prostate MRI imaging protocols.

14 July 2023 in PLOS ONE
Verified
Journal Article
Open access
PDF file
MWMitchell J. Wagner
Mitchell J. Wagner
MDMonette Dimitrov
Monette Dimitrov
GLGrace Y. Lam
Grace Y. Lam
WLWinnie Leung
Winnie Leung
GTGregory J. Tyrrell
Gregory J. Tyrrell
DVDilini Vethanayagam
Dilini Vethanayagam
Non-cystic fibrosis bronchiectasis (NCFB) is a chronic respiratory disease resulting in chronic cough, thick sputum, and lower airway microbial colonization, akin to patients with cystic fibrosis (CF). NCFB is a common, yet under recognized entity which inflicts significant morbidity and mortality particularly to older individuals, with a rising prevalence in the developed world. Given that sputum cultures are a non-invasive method to characterize the lower airway microbiota in NCFB patients, for which pathogenic organisms are associated with worsened outcomes, we sought to characterize the microbiological pattern and clinical outcomes associated with sputum culture in a cohort of NCFB patients from Western Canada. A total of 20 subjects were prospectively recruited from various bronchiectasis clinics across the Greater Edmonton area. A retrospective chart review and a symptoms questionnaire was performed, gathering information not limited to symptoms, comorbidities, exacerbations, hospitalizations, sputum production, and sputum culture results over the prior 5 years. Subjects reported frequent hospitalization alongside a significant burden of symptoms. A large majority of sputum cultures grew pathogenic organisms such as Haemophilus influenzae and Pseudomonas aeruginosa. We also note the considerable waste and inefficiency associated with sputum cultures, outlining areas for which this important diagnostic modality can be improved. Accurate characterization of the airway microbiota alongside efficient delivery of health services are key to ensuring the proper treatment of individuals with NCFB, given their high disease burden and frequent hospitalization.

1 August 2023 in British Journal of Radiology
Verified
Journal Article
Open access
MWMitchell J. Wagner
Mitchell J. Wagner
IHImaan Hussein
Imaan Hussein
Gavin LowGavin Low
Gavin Low
KSKarim Bahadurali Samji
Karim Bahadurali Samji
Objective: To determine whether a more conservative Denver criterion set could reduce unnecessary CT angiography (CTA) studies when screening for blunt cerebrovascular injury (BCVI) following blunt trauma. Methods: Following ethics approval, a retrospective chart review of 447 consecutive patients undergoing emergency CTA at two large teaching hospitals was conducted to determine the presence of risk factors for each Denver criterion set. Imaging studies of adults conducted between January 2016 and June 2020 containing sufficient clinical information for accurate classification were included in the study. Specificity, sensitivity, and predictive values were calculated. A two-sided Fisher exact test was used to evaluate the association between each iteration of the Denver criteria and the presence of BCVI. Results: The specificities of the Original, Modified, and Expanded Denver criteria were 43.58%, 34.32%, and 24.85%, respectively. Positive-predictive values (PPV) followed a different trend, with respective values of 2.77%, 3.06%, and 2.78%. Sensitivity and negative-predictive values (NPV) were found to be 100% for each criterion set. Being positive for a criterion set, and the presence of BCVI, was statistically significant for the original Denver criteria (p = 0.021, n = 443), but not the modified (p = 0.100, n = 345) or expanded Denver criteria (p = 0.202, n = 333). Conclusion: Use of the modified and expanded Denver criteria leads to the overuse of cerebrovascular imaging on patients suffering blunt force trauma. Advances in knowledge: The original Denver criteria may more appropriately identify subjects for further evaluation with CTA than the current standard, while retaining diagnostic efficacy for BCVI.

8 January 2025 in Pediatric Cardiology
Verified
Journal Article
Closed access
PDF file
MWMitchell J. Wagner
Mitchell J. Wagner
AJAamir Jeewa
Aamir Jeewa
TPTara Pidborochynski
Tara Pidborochynski
SLSamuel Lemaire-Paquette
Samuel Lemaire-Paquette
MKMichael Khoury
Michael Khoury
JCJennifer Conway
Jennifer Conway

11 December 2025 in Canadian Journal of Cardiology
Verified
Journal Article
Open access
PHParham Hassanzadeh
Parham Hassanzadeh
ALAdrien Lam
Adrien Lam
MWMitchell J. Wagner
Mitchell J. Wagner
JCJennifer Conway
Jennifer Conway
DFDarren H. Freed
Darren H. Freed
Heart transplantation remains the gold standard for end-stage heart failure, yet access is limited by geography, organ shortages, and preservation technology. In Canada, long wait times and organ underutilization persist due to the use of static cold storage (SCS), the current standard. Although SCS is cost-effective and technically simple, its short ischemic window and the inability to monitor heart function restrict donor heart viability. This review examines the evolution of preservation methods, with a focus on SCS and novel machine perfusion systems that aim to address the limitations of SCS. Hypothermic machine perfusion (HMP) and normothermic machine perfusion (NMP) both provide extended preservation times and metabolic support. HMP delivers cold, oxygenated or non-oxygenated perfusate to minimize ischemia, while NMP maintains the donor heart at body temperature in a semi-physiological state, allowing for functional monitoring and therapeutic reconditioning. Various technologies have already demonstrated success in large animal models and select clinical trials, with promising results for extended preservation intervals and DCC heart use. Normothermic regional perfusion (NRP) is a method for initial resuscitation of the DCC heart, by restoring circulation in situ before procurement and reducing ischemic injury. Its adoption in Europe and the United States (U.S.) has accelerated DCC heart donation while maintaining excellent outcomes. With new ethical guidelines supporting Canada's use, pilot programs are now possible. To improve transplant equity and maximize heart utilization, Canada can invest in machine perfusion research, infrastructure, and national implementation strategies. These technologies offer not only extended viability but also decrease waitlist mortality.